Literature DB >> 8600958

Positron emission tomography in the diagnosis and staging of urinary bladder cancer.

H Ahlström1, P U Malmström, H Letocha, J Andersson, B Långström, S Nilsson.   

Abstract

PURPOSE: Evaluation of positron emission tomography (PET) using (18)fl 18F-2-fluoro-2-deoxy-D-glucose (18FDG) and L-methyl-11C-methionine in the diagnosis and staging of urinary bladder carcinoma.
MATERIAL AND METHODS: Twenty-three patients with biopsy-proven urinary bladder carcinoma were examined with PET after intravenous injection of 11C-methionine; 2 were also examined with 18FDG. The results from the PET investigations were compared with CT or MR findings and TNM classification before and after treatment.
RESULTS: The urinary excretion of 18FDG prevented distinction of the primary tumour from the surrounding tracer. With 11C-methionine it was possible to detect 18/23 primary tumours. A trend was seen, suggesting that the higher the uptake values of 11C-methionine in the tumour, the greater the tumour stage.
CONCLUSION: It is possible to visualize urinary bladder tumours larger than 1 cm in diameter with PET using (11)C-methionine, but the value of the method in the staging of the lesions is not superior to conventional methods.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8600958     DOI: 10.1177/02841851960371P137

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  16 in total

Review 1.  Preoperative imaging for staging bladder cancer.

Authors:  Maxim J McKibben; Michael E Woods
Journal:  Curr Urol Rep       Date:  2015-04       Impact factor: 3.092

2.  Synthesis, uptake mechanism characterization and biological evaluation of (18)F labeled fluoroalkyl phenylalanine analogs as potential PET imaging agents.

Authors:  Limin Wang; Wenchao Qu; Brian P Lieberman; Karl Plössl; Hank F Kung
Journal:  Nucl Med Biol       Date:  2011-01       Impact factor: 2.408

Review 3.  PET/Computed Tomography in Renal, Bladder, and Testicular Cancer.

Authors:  Kirsten Bouchelouche; Peter L Choyke
Journal:  PET Clin       Date:  2015-04-24

4.  Utility of early dynamic and delayed post-diuretic 18F-FDG PET/CT SUVmax in predicting tumour grade and T-stage of urinary bladder carcinoma: results from a prospective single centre study.

Authors:  Abhishek Sharma; Uttam K Mete; Ashwani Sood; Nandita Kakkar; Arun K R Gorla; Bhagwant R Mittal
Journal:  Br J Radiol       Date:  2017-03-03       Impact factor: 3.039

5.  Forced diuresis and dual-phase F-fluorodeoxyglucose-PET/CT scan for restaging of urinary bladder cancers.

Authors:  S Harkirat; Ss Anand; Mj Jacob
Journal:  Indian J Radiol Imaging       Date:  2010-02

6.  PET/CT and MRI in Bladder Cancer.

Authors:  Kirsten Bouchelouche; Baris Turkbey; Peter L Choyke
Journal:  J Cancer Sci Ther       Date:  2012-07-30

Review 7.  Positron emission tomography (PET) in the urooncological evaluation of the small pelvis.

Authors:  S Machtens; J Serth; A Meyer; C Kleinhorst; K-J Ommer; U Herbst; M Kieruij; A R Boerner
Journal:  World J Urol       Date:  2007-07-12       Impact factor: 4.226

8.  [F-18]-Fluorodeoxyglucose PET and PET-CT in diagnostic imaging evaluation of locally recurrent and metastatic bladder transitional cell carcinoma.

Authors:  Hossein Jadvar; Vicki Quan; Robert W Henderson; Peter S Conti
Journal:  Int J Clin Oncol       Date:  2008-02-29       Impact factor: 3.402

9.  Positron emission tomography in uro-oncology.

Authors:  S F Hain
Journal:  Cancer Imaging       Date:  2005-01-17       Impact factor: 3.909

Review 10.  Advances in bladder cancer imaging.

Authors:  Shaista Hafeez; Robert Huddart
Journal:  BMC Med       Date:  2013-04-10       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.